Review Article
Surface-Treated versus Untreated Large-Bore Catheters as Vascular Access in Hemodialysis and Apheresis Treatments
Table 4
Potential health care cost reductions that could be achieved through the use of surface-treated catheters [
45].
| Device | Hemodialysis | Average infection (%) |
| Annual usage (devices) | 125,971 | | Infection rate (%) | 5–20 | Rate: 12 | Cost ($) of complication (due to infection) | 3.517 | | Cost ($) of coating | 12 | | Reduction of infections (%) | 10–65 | Reduction 40 | Market size (1997) ($) | 12.6 million | | Price ($) of each device (surface treatment) | 120 | | Savings ($) per year by using surface-treated devices | 17.7 milion | Reduction 40 |
|
|